NPs who want to prescribe CDS need to take one of three specified CDS prescribing courses. These courses and other requirements are outlined in the
prescribing standards, limits and conditions (pages 11-12).
NPs will also need to complete the CRNBC CDS prescribing learning module.
In addition, NPs wanting to prescribe for clients with chronic non-cancer pain require additional education.
NPs wanting to continuation prescribe buprenorphine-naloxone for opioid subsitution therapy must complete additional education. See D. Opioid Agonist Therapy | Continuation Prescribing of Buprenorphine-Naloxone in the NP Scope document.
Federal legislation excludes some drugs, such as coca and opium, from NP prescribing authority. Federal legislation limits other drugs such as amphetamine, benzphetamine, methamphetamine, phenmetrazine, and phendimetrazine, to the treatment of specific situation that require initial diagnosis and treatment by a medical specialist.
The CRNBC prescribing standards, limits and conditions, limit other drugs or restrict them to ‘continuation prescribing’. These include:
NPs in BC are not allowed to prescribe synthetic cannabinoids at this time. See CRNBC limits in the NP prescribing standards (beginning on page 26). For more information on this or other scope of practice matters, contact firstname.lastname@example.org.
No. NPs are not allowed to issue these
medical documents in BC. Federal laws have changed to allow individuals to legally possess dried leaf marijuana if it was obtained, under the Access to Cannabis for Medical Purposes regulation
from a licensed producer, with a supporting medical document from an authorized health care practitioner (either a physician or nurse practitioner). However, these changes for NPs have not been adopted by the provincial government in BC and are not included in the scope of practice of NPs at this time.
CRNBC is using a phased approach to introduce opioid agonist therapy prescribing.
As of Jan. 6, 2017, NPs can continuation prescribe buprenorphine-naloxone. See D. Opioid Agonist Therapy | Continuation Prescribing of Buprenorphine-Naloxone in the NP Scope document.
CRNBC is working with the Ministry of Health, the College of Physicians and Surgeons of BC and the College of Pharmacists of BC to introduce additional opioid agonist therapy prescribing, including methadone and buprenorphine-naloxone induction.